Milestone Pharmaceuticals Inc. Common Shares (MIST) is a publicly traded Healthcare sector company. As of November 13, 2026, MIST trades at $0.70 with a market cap of $82.44M and a P/E ratio of -1.08. MIST moved +6.38% today. Year to date, MIST is -67.72%; over the trailing twelve months it is -66.22%. Its 52-week range spans $0.63 to $3.06. Analyst consensus is strong buy with an average price target of $6.20. Rallies surfaces MIST's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks hedge fund and 13F ownership for MIST, including fund holders, share counts, and position changes when data is available.
| Metric | Value |
|---|---|
| Price | $0.70 |
| Market Cap | $82.44M |
| P/E Ratio | -1.08 |
| EPS | $-0.75 |
| Dividend Yield | 0.00% |
| 52-Week High | $3.06 |
| 52-Week Low | $0.63 |
| Volume | 189.84K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-63.06M |
| Gross Margin | 0.00% |
5 analysts cover MIST: 0 strong buy, 5 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $6.20.